Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors
SB‐219383 and its analogues are a class of potent and specific inhibitors of bacterial tyrosyl‐tRNA synthetases. Crystal structures of these inhibitors have been solved in complex with the tyrosyl‐tRNA synthetase from Staphylococcus aureus, the bacterium that is largely responsible for hospital‐acqu...
Gespeichert in:
Veröffentlicht in: | Protein science 2001-10, Vol.10 (10), p.2008-2016 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2016 |
---|---|
container_issue | 10 |
container_start_page | 2008 |
container_title | Protein science |
container_volume | 10 |
creator | Qiu, Xiayang Janson, Cheryl A. Smith, Ward W. Green, Susan M. McDevitt, Patrick Johanson, Kyung Carter, Paul Hibbs, Martin Lewis, Ceri Chalker, Alison Fosberry, Andrew Lalonde, Judith Berge, John Brown, Pamela Houge‐Frydrych, Catherine S.V. Jarvest, Richard L. |
description | SB‐219383 and its analogues are a class of potent and specific inhibitors of bacterial tyrosyl‐tRNA synthetases. Crystal structures of these inhibitors have been solved in complex with the tyrosyl‐tRNA synthetase from Staphylococcus aureus, the bacterium that is largely responsible for hospital‐acquired infections. The full‐length enzyme yielded crystals that diffracted to 2.8 Å resolution, but a truncated version of the enzyme allowed the resolution to be extended to 2.2 Å. These inhibitors not only occupy the known substrate binding sites in unique ways, but also reveal a butyl binding pocket. It was reported that the Bacillus stearothermophilus TyrRS T51P mutant has much increased catalytic activity. The S. aureus enzyme happens to have a proline at position 51. Therefore, our structures may contribute to the understanding of the catalytic mechanism and provide the structural basis for designing novel antimicrobial agents. |
doi_str_mv | 10.1110/ps.18001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2374228</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71208650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4088-3ec788ee6c1f6d1d08297c1ea6c9c81ad0e7785a6178f7ba3c0913346ad59bdd3</originalsourceid><addsrcrecordid>eNp1kc2KFDEQx4Mo7rgKPoHkJF56t6q7J52-CMuwfsDiyqrgLWTSaTuS6bSptGtfxEfwGX0Ss87gx8FTQdWPXxX1Z-whwgkiwulEJygB8BZbYS3aQrbi_W22glZgISshj9g9oo8AUGNZ3WVHiGvRQFuu2NdNXChpzynF2aQ5Wh56_ibpaVh8MMGYmbjO7VzSEgMt_se37-nq1RmnZUyDTZosdyM3YTd5-4VfuzRwzY3XRDeqKSQ7Jq7HjtNkjeudyfjgti6FSPfZnV57sg8O9Zi9e3b-dvOiuLh8_nJzdlGYGqQsKmsaKa0VBnvRYQeybBuDVgvTGom6A9s0cq0FNrJvtroy0GJV1UJ363bbddUxe7r3TvN2ZzuTT4raqym6nY6LCtqpfyejG9SH8FmVVVOXpcyCxwdBDJ9mS0ntHBnrvR5tmEk1WIIUa8jgkz1o8rMo2v73EgR1E5aaSP0KK6OP_j7qD3hIJwOne-Daebv8V6ReX10ilACy-gny2KOE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71208650</pqid></control><display><type>article</type><title>Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Qiu, Xiayang ; Janson, Cheryl A. ; Smith, Ward W. ; Green, Susan M. ; McDevitt, Patrick ; Johanson, Kyung ; Carter, Paul ; Hibbs, Martin ; Lewis, Ceri ; Chalker, Alison ; Fosberry, Andrew ; Lalonde, Judith ; Berge, John ; Brown, Pamela ; Houge‐Frydrych, Catherine S.V. ; Jarvest, Richard L.</creator><creatorcontrib>Qiu, Xiayang ; Janson, Cheryl A. ; Smith, Ward W. ; Green, Susan M. ; McDevitt, Patrick ; Johanson, Kyung ; Carter, Paul ; Hibbs, Martin ; Lewis, Ceri ; Chalker, Alison ; Fosberry, Andrew ; Lalonde, Judith ; Berge, John ; Brown, Pamela ; Houge‐Frydrych, Catherine S.V. ; Jarvest, Richard L.</creatorcontrib><description>SB‐219383 and its analogues are a class of potent and specific inhibitors of bacterial tyrosyl‐tRNA synthetases. Crystal structures of these inhibitors have been solved in complex with the tyrosyl‐tRNA synthetase from Staphylococcus aureus, the bacterium that is largely responsible for hospital‐acquired infections. The full‐length enzyme yielded crystals that diffracted to 2.8 Å resolution, but a truncated version of the enzyme allowed the resolution to be extended to 2.2 Å. These inhibitors not only occupy the known substrate binding sites in unique ways, but also reveal a butyl binding pocket. It was reported that the Bacillus stearothermophilus TyrRS T51P mutant has much increased catalytic activity. The S. aureus enzyme happens to have a proline at position 51. Therefore, our structures may contribute to the understanding of the catalytic mechanism and provide the structural basis for designing novel antimicrobial agents.</description><identifier>ISSN: 0961-8368</identifier><identifier>EISSN: 1469-896X</identifier><identifier>DOI: 10.1110/ps.18001</identifier><identifier>PMID: 11567092</identifier><language>eng</language><publisher>Bristol: Cold Spring Harbor Laboratory Press</publisher><subject>Amino Acid Sequence ; Bridged Bicyclo Compounds, Heterocyclic - chemistry ; Bridged Bicyclo Compounds, Heterocyclic - pharmacology ; bsTyrRS, Bacillus stearothermophilus TyrRS ; bsTyrRStr, C‐terminal domain truncated bsTyrRS ; Crystallization ; Crystallography, X-Ray ; Dipeptides - chemistry ; Dipeptides - pharmacology ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; Furans - chemistry ; Furans - pharmacology ; Models, Molecular ; Molecular Sequence Data ; Piperidines - chemistry ; Piperidines - pharmacology ; Protein Conformation ; Sequence Homology, Amino Acid ; Staphylococcus aureus ; Staphylococcus aureus - enzymology ; structure‐based drug design ; truncation ; Tyrosine-tRNA Ligase - antagonists & inhibitors ; Tyrosine-tRNA Ligase - chemistry ; Tyrosyl‐tRNA synthase ; TyrRS, tyrosyl‐tRNA synthetase ; YRS, Staphylococcus aureus tyrosyl‐tRNA synthetase ; YRStr, C‐terminal domain truncated YRS</subject><ispartof>Protein science, 2001-10, Vol.10 (10), p.2008-2016</ispartof><rights>Copyright © 2001 The Protein Society</rights><rights>Copyright © Copyright 2001 The Protein Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4088-3ec788ee6c1f6d1d08297c1ea6c9c81ad0e7785a6178f7ba3c0913346ad59bdd3</citedby><cites>FETCH-LOGICAL-c4088-3ec788ee6c1f6d1d08297c1ea6c9c81ad0e7785a6178f7ba3c0913346ad59bdd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374228/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374228/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,1427,27903,27904,45553,45554,46388,46812,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11567092$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Qiu, Xiayang</creatorcontrib><creatorcontrib>Janson, Cheryl A.</creatorcontrib><creatorcontrib>Smith, Ward W.</creatorcontrib><creatorcontrib>Green, Susan M.</creatorcontrib><creatorcontrib>McDevitt, Patrick</creatorcontrib><creatorcontrib>Johanson, Kyung</creatorcontrib><creatorcontrib>Carter, Paul</creatorcontrib><creatorcontrib>Hibbs, Martin</creatorcontrib><creatorcontrib>Lewis, Ceri</creatorcontrib><creatorcontrib>Chalker, Alison</creatorcontrib><creatorcontrib>Fosberry, Andrew</creatorcontrib><creatorcontrib>Lalonde, Judith</creatorcontrib><creatorcontrib>Berge, John</creatorcontrib><creatorcontrib>Brown, Pamela</creatorcontrib><creatorcontrib>Houge‐Frydrych, Catherine S.V.</creatorcontrib><creatorcontrib>Jarvest, Richard L.</creatorcontrib><title>Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors</title><title>Protein science</title><addtitle>Protein Sci</addtitle><description>SB‐219383 and its analogues are a class of potent and specific inhibitors of bacterial tyrosyl‐tRNA synthetases. Crystal structures of these inhibitors have been solved in complex with the tyrosyl‐tRNA synthetase from Staphylococcus aureus, the bacterium that is largely responsible for hospital‐acquired infections. The full‐length enzyme yielded crystals that diffracted to 2.8 Å resolution, but a truncated version of the enzyme allowed the resolution to be extended to 2.2 Å. These inhibitors not only occupy the known substrate binding sites in unique ways, but also reveal a butyl binding pocket. It was reported that the Bacillus stearothermophilus TyrRS T51P mutant has much increased catalytic activity. The S. aureus enzyme happens to have a proline at position 51. Therefore, our structures may contribute to the understanding of the catalytic mechanism and provide the structural basis for designing novel antimicrobial agents.</description><subject>Amino Acid Sequence</subject><subject>Bridged Bicyclo Compounds, Heterocyclic - chemistry</subject><subject>Bridged Bicyclo Compounds, Heterocyclic - pharmacology</subject><subject>bsTyrRS, Bacillus stearothermophilus TyrRS</subject><subject>bsTyrRStr, C‐terminal domain truncated bsTyrRS</subject><subject>Crystallization</subject><subject>Crystallography, X-Ray</subject><subject>Dipeptides - chemistry</subject><subject>Dipeptides - pharmacology</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Furans - chemistry</subject><subject>Furans - pharmacology</subject><subject>Models, Molecular</subject><subject>Molecular Sequence Data</subject><subject>Piperidines - chemistry</subject><subject>Piperidines - pharmacology</subject><subject>Protein Conformation</subject><subject>Sequence Homology, Amino Acid</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - enzymology</subject><subject>structure‐based drug design</subject><subject>truncation</subject><subject>Tyrosine-tRNA Ligase - antagonists & inhibitors</subject><subject>Tyrosine-tRNA Ligase - chemistry</subject><subject>Tyrosyl‐tRNA synthase</subject><subject>TyrRS, tyrosyl‐tRNA synthetase</subject><subject>YRS, Staphylococcus aureus tyrosyl‐tRNA synthetase</subject><subject>YRStr, C‐terminal domain truncated YRS</subject><issn>0961-8368</issn><issn>1469-896X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc2KFDEQx4Mo7rgKPoHkJF56t6q7J52-CMuwfsDiyqrgLWTSaTuS6bSptGtfxEfwGX0Ss87gx8FTQdWPXxX1Z-whwgkiwulEJygB8BZbYS3aQrbi_W22glZgISshj9g9oo8AUGNZ3WVHiGvRQFuu2NdNXChpzynF2aQ5Wh56_ibpaVh8MMGYmbjO7VzSEgMt_se37-nq1RmnZUyDTZosdyM3YTd5-4VfuzRwzY3XRDeqKSQ7Jq7HjtNkjeudyfjgti6FSPfZnV57sg8O9Zi9e3b-dvOiuLh8_nJzdlGYGqQsKmsaKa0VBnvRYQeybBuDVgvTGom6A9s0cq0FNrJvtroy0GJV1UJ363bbddUxe7r3TvN2ZzuTT4raqym6nY6LCtqpfyejG9SH8FmVVVOXpcyCxwdBDJ9mS0ntHBnrvR5tmEk1WIIUa8jgkz1o8rMo2v73EgR1E5aaSP0KK6OP_j7qD3hIJwOne-Daebv8V6ReX10ilACy-gny2KOE</recordid><startdate>200110</startdate><enddate>200110</enddate><creator>Qiu, Xiayang</creator><creator>Janson, Cheryl A.</creator><creator>Smith, Ward W.</creator><creator>Green, Susan M.</creator><creator>McDevitt, Patrick</creator><creator>Johanson, Kyung</creator><creator>Carter, Paul</creator><creator>Hibbs, Martin</creator><creator>Lewis, Ceri</creator><creator>Chalker, Alison</creator><creator>Fosberry, Andrew</creator><creator>Lalonde, Judith</creator><creator>Berge, John</creator><creator>Brown, Pamela</creator><creator>Houge‐Frydrych, Catherine S.V.</creator><creator>Jarvest, Richard L.</creator><general>Cold Spring Harbor Laboratory Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200110</creationdate><title>Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors</title><author>Qiu, Xiayang ; Janson, Cheryl A. ; Smith, Ward W. ; Green, Susan M. ; McDevitt, Patrick ; Johanson, Kyung ; Carter, Paul ; Hibbs, Martin ; Lewis, Ceri ; Chalker, Alison ; Fosberry, Andrew ; Lalonde, Judith ; Berge, John ; Brown, Pamela ; Houge‐Frydrych, Catherine S.V. ; Jarvest, Richard L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4088-3ec788ee6c1f6d1d08297c1ea6c9c81ad0e7785a6178f7ba3c0913346ad59bdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Amino Acid Sequence</topic><topic>Bridged Bicyclo Compounds, Heterocyclic - chemistry</topic><topic>Bridged Bicyclo Compounds, Heterocyclic - pharmacology</topic><topic>bsTyrRS, Bacillus stearothermophilus TyrRS</topic><topic>bsTyrRStr, C‐terminal domain truncated bsTyrRS</topic><topic>Crystallization</topic><topic>Crystallography, X-Ray</topic><topic>Dipeptides - chemistry</topic><topic>Dipeptides - pharmacology</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Furans - chemistry</topic><topic>Furans - pharmacology</topic><topic>Models, Molecular</topic><topic>Molecular Sequence Data</topic><topic>Piperidines - chemistry</topic><topic>Piperidines - pharmacology</topic><topic>Protein Conformation</topic><topic>Sequence Homology, Amino Acid</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - enzymology</topic><topic>structure‐based drug design</topic><topic>truncation</topic><topic>Tyrosine-tRNA Ligase - antagonists & inhibitors</topic><topic>Tyrosine-tRNA Ligase - chemistry</topic><topic>Tyrosyl‐tRNA synthase</topic><topic>TyrRS, tyrosyl‐tRNA synthetase</topic><topic>YRS, Staphylococcus aureus tyrosyl‐tRNA synthetase</topic><topic>YRStr, C‐terminal domain truncated YRS</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qiu, Xiayang</creatorcontrib><creatorcontrib>Janson, Cheryl A.</creatorcontrib><creatorcontrib>Smith, Ward W.</creatorcontrib><creatorcontrib>Green, Susan M.</creatorcontrib><creatorcontrib>McDevitt, Patrick</creatorcontrib><creatorcontrib>Johanson, Kyung</creatorcontrib><creatorcontrib>Carter, Paul</creatorcontrib><creatorcontrib>Hibbs, Martin</creatorcontrib><creatorcontrib>Lewis, Ceri</creatorcontrib><creatorcontrib>Chalker, Alison</creatorcontrib><creatorcontrib>Fosberry, Andrew</creatorcontrib><creatorcontrib>Lalonde, Judith</creatorcontrib><creatorcontrib>Berge, John</creatorcontrib><creatorcontrib>Brown, Pamela</creatorcontrib><creatorcontrib>Houge‐Frydrych, Catherine S.V.</creatorcontrib><creatorcontrib>Jarvest, Richard L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Protein science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qiu, Xiayang</au><au>Janson, Cheryl A.</au><au>Smith, Ward W.</au><au>Green, Susan M.</au><au>McDevitt, Patrick</au><au>Johanson, Kyung</au><au>Carter, Paul</au><au>Hibbs, Martin</au><au>Lewis, Ceri</au><au>Chalker, Alison</au><au>Fosberry, Andrew</au><au>Lalonde, Judith</au><au>Berge, John</au><au>Brown, Pamela</au><au>Houge‐Frydrych, Catherine S.V.</au><au>Jarvest, Richard L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors</atitle><jtitle>Protein science</jtitle><addtitle>Protein Sci</addtitle><date>2001-10</date><risdate>2001</risdate><volume>10</volume><issue>10</issue><spage>2008</spage><epage>2016</epage><pages>2008-2016</pages><issn>0961-8368</issn><eissn>1469-896X</eissn><abstract>SB‐219383 and its analogues are a class of potent and specific inhibitors of bacterial tyrosyl‐tRNA synthetases. Crystal structures of these inhibitors have been solved in complex with the tyrosyl‐tRNA synthetase from Staphylococcus aureus, the bacterium that is largely responsible for hospital‐acquired infections. The full‐length enzyme yielded crystals that diffracted to 2.8 Å resolution, but a truncated version of the enzyme allowed the resolution to be extended to 2.2 Å. These inhibitors not only occupy the known substrate binding sites in unique ways, but also reveal a butyl binding pocket. It was reported that the Bacillus stearothermophilus TyrRS T51P mutant has much increased catalytic activity. The S. aureus enzyme happens to have a proline at position 51. Therefore, our structures may contribute to the understanding of the catalytic mechanism and provide the structural basis for designing novel antimicrobial agents.</abstract><cop>Bristol</cop><pub>Cold Spring Harbor Laboratory Press</pub><pmid>11567092</pmid><doi>10.1110/ps.18001</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0961-8368 |
ispartof | Protein science, 2001-10, Vol.10 (10), p.2008-2016 |
issn | 0961-8368 1469-896X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2374228 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Free Content; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Amino Acid Sequence Bridged Bicyclo Compounds, Heterocyclic - chemistry Bridged Bicyclo Compounds, Heterocyclic - pharmacology bsTyrRS, Bacillus stearothermophilus TyrRS bsTyrRStr, C‐terminal domain truncated bsTyrRS Crystallization Crystallography, X-Ray Dipeptides - chemistry Dipeptides - pharmacology Enzyme Inhibitors - chemistry Enzyme Inhibitors - pharmacology Furans - chemistry Furans - pharmacology Models, Molecular Molecular Sequence Data Piperidines - chemistry Piperidines - pharmacology Protein Conformation Sequence Homology, Amino Acid Staphylococcus aureus Staphylococcus aureus - enzymology structure‐based drug design truncation Tyrosine-tRNA Ligase - antagonists & inhibitors Tyrosine-tRNA Ligase - chemistry Tyrosyl‐tRNA synthase TyrRS, tyrosyl‐tRNA synthetase YRS, Staphylococcus aureus tyrosyl‐tRNA synthetase YRStr, C‐terminal domain truncated YRS |
title | Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T13%3A22%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Crystal%20structure%20of%20Staphylococcus%20aureus%20tyrosyl%E2%80%90tRNA%20synthetase%20in%20complex%20with%20a%20class%20of%20potent%20and%20specific%20inhibitors&rft.jtitle=Protein%20science&rft.au=Qiu,%20Xiayang&rft.date=2001-10&rft.volume=10&rft.issue=10&rft.spage=2008&rft.epage=2016&rft.pages=2008-2016&rft.issn=0961-8368&rft.eissn=1469-896X&rft_id=info:doi/10.1110/ps.18001&rft_dat=%3Cproquest_pubme%3E71208650%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71208650&rft_id=info:pmid/11567092&rfr_iscdi=true |